Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
Advanced Drug Delivery Reviews
|
December 3, 2014
Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development
Christine Unger, Nina Kramer, Angelika Walzl, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 28, 2017
An Optimized 3D Coculture Assay for Preclinical Testing of Pro- and Antiangiogenic Drugs
Daniela Unterleuthner, Nina Kramer, Karoline Pudelko, et al.
Blood
|
May 29, 2004
Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells
Sebastian Carotta, Sandra Pilat, Andreas Mairhofer, et al.
Mutation Research
|
September 4, 2012
In vitro cell migration and invasion assays
Nina Kramer, Angelika Walzl, Christine Unger, et al.
RNA (New York, N.Y.)
|
January 24, 2007
Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments
M Julieta del Prete, Rolando Vernal, Helmut Dolznig, et al.
Current Biology : CB
|
July 18, 2002
Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts
Helmut Dolznig, Bianca Habermann, Katharina Stangl, et al.
Cancer Immunity
|
August 4, 2005
Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin
Helmut Dolznig, Norbert Schweifer, Christina Puri, et al.
Methods in Molecular Medicine
|
October 20, 2004
Expansion and differentiation of immature mouse and human hematopoietic progenitors
Helmut Dolznig, Andrea Kolbus, Cornelia Leberbauer, et al.
Cancer Immunity
|
August 1, 2006
Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis
Christian Rupp, Helmut Dolznig, Christina Puri, et al.
Journal of Biomolecular Screening
|
April 25, 2014
The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays
Angelika Walzl, Christine Unger, Nina Kramer, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
Advanced Drug Delivery Reviews
|
December 3, 2014
Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development
Christine Unger, Nina Kramer, Angelika Walzl, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 28, 2017
An Optimized 3D Coculture Assay for Preclinical Testing of Pro- and Antiangiogenic Drugs
Daniela Unterleuthner, Nina Kramer, Karoline Pudelko, et al.
Blood
|
May 29, 2004
Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells
Sebastian Carotta, Sandra Pilat, Andreas Mairhofer, et al.
Mutation Research
|
September 4, 2012
In vitro cell migration and invasion assays
Nina Kramer, Angelika Walzl, Christine Unger, et al.
RNA (New York, N.Y.)
|
January 24, 2007
Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments
M Julieta del Prete, Rolando Vernal, Helmut Dolznig, et al.
Current Biology : CB
|
July 18, 2002
Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts
Helmut Dolznig, Bianca Habermann, Katharina Stangl, et al.
Cancer Immunity
|
August 4, 2005
Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin
Helmut Dolznig, Norbert Schweifer, Christina Puri, et al.
Methods in Molecular Medicine
|
October 20, 2004
Expansion and differentiation of immature mouse and human hematopoietic progenitors
Helmut Dolznig, Andrea Kolbus, Cornelia Leberbauer, et al.
Cancer Immunity
|
August 1, 2006
Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis
Christian Rupp, Helmut Dolznig, Christina Puri, et al.
Journal of Biomolecular Screening
|
April 25, 2014
The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays
Angelika Walzl, Christine Unger, Nina Kramer, et al.
Page
of 8